ADLI, M. Et Al. 2019. 18F-FDG PET/CT Uptake as a Predictor of Tumor Response in Neoadjuvant Treatment of Rectal Cancer with Dose Escalation using Simultaneous Integrated Boost. 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) , 160.

ADLI, M., GÜLEĞEN, B. Z., ALKIŞ, H., ÖNEŞ, T., ÖZGÜVEN, S., & KOÇ, M., (2019). 18F-FDG PET/CT Uptake as a Predictor of Tumor Response in Neoadjuvant Treatment of Rectal Cancer with Dose Escalation using Simultaneous Integrated Boost . 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) (pp.160).

ADLI, MUSTAFA Et Al. "18F-FDG PET/CT Uptake as a Predictor of Tumor Response in Neoadjuvant Treatment of Rectal Cancer with Dose Escalation using Simultaneous Integrated Boost," 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2019

ADLI, MUSTAFA Et Al. "18F-FDG PET/CT Uptake as a Predictor of Tumor Response in Neoadjuvant Treatment of Rectal Cancer with Dose Escalation using Simultaneous Integrated Boost." 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) , pp.160, 2019

ADLI, M. Et Al. (2019) . "18F-FDG PET/CT Uptake as a Predictor of Tumor Response in Neoadjuvant Treatment of Rectal Cancer with Dose Escalation using Simultaneous Integrated Boost." 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) , p.160.

@conferencepaper{conferencepaper, author={MUSTAFA ADLI Et Al. }, title={18F-FDG PET/CT Uptake as a Predictor of Tumor Response in Neoadjuvant Treatment of Rectal Cancer with Dose Escalation using Simultaneous Integrated Boost}, congress name={61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)}, city={}, country={}, year={2019}, pages={160} }